DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Packaging Offered, Scale of Operation, End Users and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.
The Pharmaceutical Contract Manufacturing Market is valued at USD 99 billion in 2024 growing at a CAGR of 4.3% during the forecast period 2024-2035.
In the rapidly evolving pharmaceutical landscape, small molecule drugs continue to play a pivotal role in shaping innovation and development. Currently, small molecules account for 90% of all pharmaceutical drugs, even as biologics have gained more attention in recent years due to their ability to address a wide range of disorders.
The sector has also seen a resurgence in the approval of novel small molecule drugs, with over 50 candidates receiving approval from the US FDA in 2020 alone. This trend has significantly boosted the demand for services provided by pharmaceutical contract research organizations (CROs).
It is important to note that the manufacturing of these novel drug candidates necessitates specialized facilities, advanced equipment, and operational expertise. Consequently, pharmaceutical companies may face challenges in conducting development and manufacturing operations independently.
Additionally, the time and cost associated with establishing or acquiring manufacturing capabilities have driven both small and large pharmaceutical companies to increasingly outsource their manufacturing operations to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). The pressing need for safer and more effective drugs has further heightened the demand for contract manufacturing services.
Influenced by the desire for improved efficiency, traceability, and cost-effectiveness, pharmaceutical contract manufacturing is undergoing significant technological advancements. Outsourcing manufacturing operations to CMOs and CDMOs involves implementing specialized solutions to optimize production workflows, ensure regulatory compliance, and uphold product quality standards.
Moreover, there is a growing focus on personalized medicine, which requires flexible manufacturing capabilities to cater to diverse patient needs. As pharmaceutical companies adapt to these evolving dynamics, the demand for advanced solutions tailored to the specific requirements of contract manufacturing services is anticipated to increase in the coming years.
Key Benefits of Buying this Report
- The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
- Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
- The report provides stakeholders with a pulse on the Pharmaceutical Contract Manufacturing Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
- AMRI Global
- Altasciences
- Cambrex
- Catalent
- DPT Laboratories
- Aenova
- Almac
- Corden Pharma
- Fresenius Kabi
- Glatt
- Hovione
- Recipharm
- Siegfried
- CMIC Group
- Nectar Lifesciences
- Syngene
- WuXi AppTec
Key Topics Covered:
1. PREFACE
2. RESEARCH METHODOLOGY
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Overview of Pharmaceutical Packaging
5.3. Advantages of Pharmaceutical Packaging
5.4. Types of Pharmaceutical Packaging
5.5. Need for Sustainable Pharmaceutical Packaging
5.6. Sustainable Pharmaceutical Packaging Solutions
5.7. Regulatory Framework
5.8. Advantages of Sustainable Packaging Materials
5.9. Limitations of Sustainable Packaging Materials
5.10. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Sustainable Packaging Providers: Overall Market Landscape
7. DETAILED COMPANY PROFILES
7.1. Chapter Overview
7.2. Drug Plastics
7.3. DS SMITH
7.4. MM Board & Paper
7.5. Mondi
7.6. PGP GLASS
7.7. Smurfit Kappa
7.8. Syntegon
7.9. Berry Global
7.10. Huhtamaki
7.11. SGD Pharma
8. SHORT COMPANY PROFILES
8.1. Chapter Overview
8.2. Amcor
8.3. Bormioli Pharma
8.4. EPL
8.5. Gerresheimer
8.6. Greiner Packaging
8.7. International Paper
8.8. PPC Flexible Packaging
8.9. Stoelzle Glass
8.10. Takemoto Packaging
8.11. Tekni-Plex
9. COMPANY COMPETITIVENESS ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Sustainable Packaging Providers: Company Competitiveness Analysis
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Sustainable Packaging Providers: Partnerships and Collaborations
11. FUNDING AND INVESTMENTS
11.1. Chapter Overview
11.2. Funding Models
11.3. Sustainable Packaging Providers: Funding and Investments
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
13. DEMAND ANALYSIS
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Demand for Sustainable Packaging in Healthcare Industry, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
14. GLOBAL SUSTAINABLE PACKAGING MARKET
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Global Sustainable Packaging Market, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
15. SUSTAINABLE PACKAGING MARKET, BY TYPE OF ECO-FRIENDLY PACKAGING
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Sustainable Packaging Market: Distribution by Eco-friendly Packaging, 2024, 2028 and 2035
16. SUSTAINABLE PACKAGING MARKET, BY TYPE OF PACKAGING
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Sustainable Packaging Market: Distribution by Type of Packaging, 2024, 2028 and 2035
17. SUSTAINABLE PACKAGING MARKET, BY TYPE OF PACKAGING CONTAINER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Sustainable Packaging Market for Primary Packaging Containers
17.4. Sustainable Packaging Market for Secondary Packaging Containers
17.5. Sustainable Packaging Market for Tertiary Packaging Containers
18. SUSTAINABLE PACKAGING MARKET, BY END-USERS
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Sustainable Packaging Market: Distribution by End-users, 2024, 2028 and 2035
19. SUSTAINABLE PACKAGING MARKET, BY KEY GEOGRAPHICAL REGIONS
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Sustainable Packaging Market: Distribution by Key Geographical Regions, 2024, 2028 and 2035
20. CONCLUSION
21. EXECUTIVE INSIGHTS
For more information about this report visit https://www.researchandmarkets.com/r/665x2b
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
